Glen R. Hanson, DDS, PhD

Research Interests

  • Receptors, Dopamine
  • Cardiac Electrophysiology
  • Microdialysis
  • Serotonergic Ligands
  • Stimulants of Abuse
  • Free Radicals
  • Ganglia, Sensory
  • Monoamines
  • Neuropeptides
  • Glutamates
  • Plasmalemmal and Vesicular Transporters
  • Transmitter Release
  • Cholinergic Transmitter Systems
  • Substance P
  • Neurochemistry
  • Excitatory Amino Acids
  • Cholinergic Ligands
  • Antipsychotics
  • Norepinephrine

Languages

  • English

Academic Information

  • Departments: Dentistry - Professor, Pharmacology and Toxicology - Professor

Academic Office Information

  • 801-581-3174
  • Ray and Tye Noorda Oral Health Sciences Building
    School of Dentistry
    530 South Wakara Way, Room: 3014
    Salt Lake City, UT 84108

Education History

Type School Degree
Postdoctoral Fellowship National Institutes of Health (National Heart, Lung and Blood Institute)
Postdoctoral Fellow
Doctoral Training University of Utah
Pharmacology
Ph.D.
Professional Dental University of California at Los Angeles
Dentistry
D.D.S.
Undergraduate Brigham Young University

Selected Publications

Journal Article

  1. Jones CE, Zandawala M, Semmens DC, Anderson S, Hanson GR, Janies DA, Elphick MR (2016). Identification of a neuropeptide precursor protein that gives rise to a "cocktail" of peptides that bind Cu(II) and generate metal-linked dimers. Biochim Biophys Acta, 1860(1 Pt A), 57-66.
  2. Fricks-Gleason AN, German CL, Hoonakker AJ, Friend DM, Ganesh KK, Carver AS, Hanson GR, Fleckenstein AE, Keefe KA (2016). An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse, 70(4), 139-46.
  3. Baladi MG, Nielsen SM, McIntosh JM, Hanson GR, Fleckenstein AE (2016). Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behav Pharmacol, 27(5), 422-30.
  4. Pittenger ST, Swalve N, Chou S, Smith MD, Hoonakker AJ, Pudiak CM, Fleckenstein AE, Hanson GR, Bevins RA (2016). Sex differences in neurotensin and substance P following nicotine self-administration in rats. Synapse, 70(8), 336-46.
  5. Kilmartin JR, Bernhardt PV, Dhouib R, Hanson GR, Riley MJ, Kappler U (2016). Effects of mutations in active site heme ligands on the spectroscopic and catalytic properties of SoxAX cytochromes. J Inorg Biochem, 162, 309-318.
  6. Barak LS, Bai Y, Peterson S, Evron T, Urs NM, Peddibhotla S, Hedrick MP, Hershberger P, Maloney PR, Chung TD, Rodriguiz RM, Wetsel WC, Thomas JB, Hanson GR, Pinkerton AB, Caron MG (2016). ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse. ACS Chem Biol, 11(7), 1880-90.
  7. Comba P, Eisenschmidt A, Gahan LR, Hanson GR, Mehrkens N, Westphal M (2016). Dinuclear ZnII and mixed CuII-ZnII complexes of artificial patellamides as phosphatase models. Dalton Trans, 45(47), 18931-18945.
  8. Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015). Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment. Drug Alcohol Depend, 146, 30-8.
  9. McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE (2015). Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology, 93, 146-54.
  10. Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR (2015). Effect of low doses of methamphetamine on rat limbic-related neurotensin systems. Synapse, 69(8), 396-404.
  11. Vieira-Brock PL, McFadden LM, Nielsen SM, Smith MD, Hanson GR, Fleckenstein AE (2015). Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.LID - 10.1093/ijnp/pyv073 [doi]LID - pyv073 [pii]. Int J Neuropsychopharmacol, 18(12).
  12. Bernhardt PV, Bosch S, Comba P, Gahan LR, Hanson GR, Mereacre V, Noble CJ, Powell AK, Schenk G, Wadepohl H (2015). An Approach to More Accurate Model Systems for Purple Acid Phosphatases (PAPs). Inorg Chem, 54(15), 7249-63.
  13. Vieira-Brock PL, McFadden LM, Nielsen SM, Ellis JD, Walters ET, Stout KA, McIntosh JM, Wilkins DG, Hanson GR, Fleckenstein AE (2015). Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. J Pharmacol Exp Ther, 355(3), 463-72.
  14. Bosch S, Comba P, Gahan LR, Hanson GR, Noble C, Schenk G, Wadepohl H (2015). Selective Coordination of Gallium(III), Zinc(II), and Copper(II) by an Asymmetric Dinucleating Ligand: A Model for Metallophosphatases. Chemistry, 21(50), 18269-79.
  15. Rienecker SB, Mostert AB, Schenk G, Hanson GR, Meredith P (2015). Heavy Water as a Probe of the Free Radical Nature and Electrical Conductivity of Melanin. J Phys Chem B, 119(48), 14994-5000.
  16. McGrath AP, Laming EL, Casas Garcia GP, Kvansakul M, Guss JM, Trewhella J, Calmes B, Bernhardt PV, Hanson GR, Kappler U, Maher MJ (2015). Structural basis of interprotein electron transfer in bacterial sulfite oxidation. Elife, 4, e09066.

Review

  1. German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE (2015). Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. [Review]. Pharmacol Rev, 67(4), 1005-24.

News

Video